These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28195673)

  • 1. Ultrasound-Enhanced siRNA Delivery Using Magnetic Nanoparticle-Loaded Chitosan-Deoxycholic Acid Nanodroplets.
    Lee JY; Crake C; Teo B; Carugo D; de Saint Victor M; Seth A; Stride E
    Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28195673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer.
    Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
    Biologicals; 2016 Nov; 44(6):487-496. PubMed ID: 27712979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
    Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
    J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles.
    Unsoy G; Gunduz U
    Expert Rev Anticancer Ther; 2016 Jul; 16(7):789-97. PubMed ID: 27130312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Superparamagnetic Nanoparticles: From Synthesis to siRNA Delivery.
    Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
    Curr Pharm Des; 2017; 23(16):2400-2409. PubMed ID: 27799034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
    Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
    Huo M; Zou A; Yao C; Zhang Y; Zhou J; Wang J; Zhu Q; Li J; Zhang Q
    Biomaterials; 2012 Sep; 33(27):6393-407. PubMed ID: 22704599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells.
    Muddineti OS; Shah A; Rompicharla SVK; Ghosh B; Biswas S
    Int J Biol Macromol; 2018 Oct; 118(Pt A):857-863. PubMed ID: 29953893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.
    Mykhaylyk O; Sanchez-Antequera Y; Vlaskou D; Cerda MB; Bokharaei M; Hammerschmid E; Anton M; Plank C
    Methods Mol Biol; 2015; 1218():53-106. PubMed ID: 25319646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
    Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
    J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA.
    Guo L; Shi D; Shang M; Sun X; Meng D; Liu X; Zhou X; Li J
    Drug Deliv; 2022 Dec; 29(1):316-327. PubMed ID: 35037525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro.
    Yan L; Gao S; Shui S; Liu S; Qu H; Liu C; Zheng L
    Int J Biol Macromol; 2020 Nov; 162():1303-1310. PubMed ID: 32603733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional gene silencing mediated by chitosan/siRNA nanocomplexes.
    Ji AM; Su D; Che O; Li WS; Sun L; Zhang ZY; Yang B; Xu F
    Nanotechnology; 2009 Oct; 20(40):405103. PubMed ID: 19752491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
    Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
    Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
    Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
    J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.